169 related articles for article (PubMed ID: 3495637)
1. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.
Phadke JG
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):523-31. PubMed ID: 3495637
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.
Phadke JG
Brain; 1990 Dec; 113 ( Pt 6)():1597-628. PubMed ID: 2276037
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of multiple sclerosis in north-east Scotland.
Shepherd DI
Acta Neurol Scand; 1979 Oct; 60(4):218-30. PubMed ID: 160740
[TBL] [Abstract][Full Text] [Related]
4. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
Cottrell DA; Kremenchutzky M; Rice GP; Koopman WJ; Hader W; Baskerville J; Ebers GC
Brain; 1999 Apr; 122 ( Pt 4)():625-39. PubMed ID: 10219776
[TBL] [Abstract][Full Text] [Related]
5. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
[TBL] [Abstract][Full Text] [Related]
6. Survival in multiple sclerosis.
Poser S; Kurtzke JF; Poser W; Schlaf G
J Clin Epidemiol; 1989; 42(2):159-68. PubMed ID: 2918325
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland--an update.
Phadke JG; Downie AW
J Epidemiol Community Health; 1987 Mar; 41(1):5-13. PubMed ID: 3668459
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey.
Brønnum-Hansen H; Koch-Henriksen N; Hyllested K
Neurology; 1994 Oct; 44(10):1901-7. PubMed ID: 7936244
[TBL] [Abstract][Full Text] [Related]
9. [Survival in disseminated sclerosis in Denmark. A nation-wide study of the period 1948-1986].
Brønnum-Hansen H; Koch-Henriksen NJ; Hyllested K
Ugeskr Laeger; 1995 Dec; 157(51):7131-5. PubMed ID: 8545927
[TBL] [Abstract][Full Text] [Related]
10. Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
Leray E; Vukusic S; Debouverie M; Clanet M; Brochet B; de Sèze J; Zéphir H; Defer G; Lebrun-Frenay C; Moreau T; Clavelou P; Pelletier J; Berger E; Cabre P; Camdessanché JP; Kalson-Ray S; Confavreux C; Edan G
PLoS One; 2015; 10(7):e0132033. PubMed ID: 26148099
[TBL] [Abstract][Full Text] [Related]
11. Causes of death among persons with multiple sclerosis.
Cutter GR; Zimmerman J; Salter AR; Knappertz V; Suarez G; Waterbor J; Howard VJ; Marrie RA
Mult Scler Relat Disord; 2015 Sep; 4(5):484-490. PubMed ID: 26346799
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.
Soutar RL; Dawson AA; Wilson BJ
Health Bull (Edinb); 1996 May; 54(3):232-40. PubMed ID: 8707567
[TBL] [Abstract][Full Text] [Related]
13. Survival of multiple sclerosis in Finland between 1964 and 1993.
Sumelahti ML; Tienari PJ; Wikström J; Salminen TM; Hakama M
Mult Scler; 2002 Aug; 8(4):350-5. PubMed ID: 12166507
[TBL] [Abstract][Full Text] [Related]
14. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
[TBL] [Abstract][Full Text] [Related]
15. A long perspective on childhood multiple sclerosis.
Cole GF; Stuart CA
Dev Med Child Neurol; 1995 Aug; 37(8):661-6. PubMed ID: 7672462
[TBL] [Abstract][Full Text] [Related]
16. Disability and survival of multiple sclerosis in Saskatoon, Saskatchewan.
Hader WJ
Can J Neurol Sci; 2010 Jan; 37(1):28-35. PubMed ID: 20169770
[TBL] [Abstract][Full Text] [Related]
17. Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
Papais-Alvarenga RM; Vasconcelos CC; Carra A; de Castillo IS; Florentin S; Diaz de Bedoya FH; Mandler R; de Siervi LC; Pimentel ML; Alvarenga MP; Alvarenga MP; Grzesiuk AK; Gama Pereira AB; Gomes Neto AP; Velasquez C; Soublette C; Fleitas CV; Diniz DS; Armas E; Batista E; Hernandez F; Pereira FF; Siqueira HH; Cabeça H; Sanchez J; Brooks JB; Gonçalves MV; Barroso MC; Ravelo ME; Castillo MC; Ferreira ML; Rocha MS; Parolin MK; Molina O; Marinho PB; Christo PP; Brant de Souza R; Pessanha Neto S; Camargo SM; Machado SC; Neri VC; Fragoso YD; Alvarenga H; Thuler LC
PLoS One; 2015; 10(7):e0127757. PubMed ID: 26222205
[TBL] [Abstract][Full Text] [Related]
18. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.
Hawkins SA; McDonnell GV
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):148-52. PubMed ID: 10406979
[TBL] [Abstract][Full Text] [Related]
19. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
Lunde HMB; Assmus J; Myhr KM; Bø L; Grytten N
J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):621-625. PubMed ID: 28365589
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway.
Midgard R; Albrektsen G; Riise T; Kvåle G; Nyland H
J Neurol Neurosurg Psychiatry; 1995 Apr; 58(4):417-21. PubMed ID: 7738546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
